Add BrightSurf on Google Email

New discoveries in lupus research

Researchers at the University of Houston have identified blood biomarkers predicting heart disease in lupus patients and urine biomarkers for diagnosing kidney inflammation in children with lupus. These findings hold promise for early preventive measures and improved treatment outcomes.

SourceUniversity of Houston·JournalFrontiers in Cardiovascular Medicine·DateJun 2, 2022

COVID kidney injury twice as common as diagnosed

A University of Queensland-led study found that millions of COVID-19 patients may have undiagnosed acute kidney injury (AKI), which can lead to serious illness or death. The true AKI diagnosis rates are likely double existing data, highlighting the need for improved detection and management strategies.

SourceUniversity of Queensland·JournalPLOS Medicine·TypeObservational study·DateJun 2, 2022

Metals found in people’s urine could detect acute kidney injury in very early stages, says new study

Scientists have discovered that certain metals found in people's urine could be potentially useful clinical biomarkers for the early detection of acute kidney injury (AKI). The study, which was led by experts from the University of Nottingham, found that concentrations of these metals rose in urine within an hour after cardiac surgery ...

SourceUniversity of Nottingham·JournalKidney International Reports·TypeExperimental study·DateMay 30, 2022

Kyoto scientists discover ‘crack team’ of kidney cells that are key to disease recovery

Researchers at Kyoto University identify a distinct subpopulation of fibroblasts responsible for producing the hormone erythropoietin (Epo), which stimulates red blood cell production. This discovery provides insight into renal anemia and may lead to novel treatment methods for patients with chronic kidney disease.

SourceKyoto University·JournalKidney International·TypeExperimental study·DateMay 27, 2022

New research questions previous link between diabetes drugs and bone fractures

A recent study published in CJASN found that SGLT-2 inhibitors were not associated with an increased risk of fractures in adults with chronic kidney disease, regardless of their kidney function. The study included over 38,000 new users of the medications and compared them to those prescribed a different diabetes medication.

SourceAmerican Society of Nephrology·JournalJournal of the American Society of Nephrology·DateMay 26, 2022

COVID-19 can directly infect and damage human kidney cells

Researchers at Duke University discovered that SARS-CoV-2, the virus causing COVID-19, can directly infect and damage specific types of kidney cells. The virus hijacks the cell's machinery to replicate, leading to structural damage and increased production of viral particles.

SourceDuke University·JournalFrontiers in Cell and Developmental Biology·TypeExperimental study·DateApr 21, 2022

Study: Black kidney transplant patients exhibit faster clearance rates of key immunosuppressive medicine tacrolimus

A new study found that Black kidney transplant recipients exhibit a faster clearance rate of tacrolimus, an immunosuppressive drug. The study suggests that considering both sex and race when dosing tacrolimus may reduce adverse effects and enhance transplant outcomes.

SourceUniversity at Buffalo·JournalPharmacotherapy The Journal of Human Pharmacology and Drug Therapy·DateApr 18, 2022

Low-dose lithium may slow kidney aging

Researchers at The University of Toledo found that low-dose lithium acts as a powerful anti-aging agent in the kidneys by blocking GSK3-beta, an enzyme associated with cellular aging. Studies showed improved kidney function and reduced albuminuria in mice and psychiatric patients treated with lithium.

SourceUniversity of Toledo·JournalJournal of Clinical Investigation·TypeExperimental study·DateApr 12, 2022

The “Deciding Not to Decide” option can improve older adult patient care

A new study suggests including the 'Deciding Not to Decide' treatment option can improve care for older adults with chronic kidney disease, giving them more time to make informed decisions about their treatment. Researchers argue that this approach strengthens patient-centered care and increases patient autonomy.

SourceRutgers University·JournalJournal of the American Society of Nephrology·TypeObservational study·DateMar 16, 2022

Physiological effects of peripheral amyloid-β elucidated - Type 2 diabetes seen as major risk to development of Alzheimer’s disease

Researchers identified peripheral tissues as source of blood amyloid beta, which regulates blood glucose levels and suppresses insulin secretion. The study suggests a possible mechanism linking type 2 diabetes to Alzheimer's disease development.

SourceOsaka City University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMar 14, 2022

Could a community-based approach to genetic testing help African Americans reduce risks of chronic kidney disease?

Researchers found that a community-based approach to reporting APOL1 genetic test results resulted in lower blood pressure readings among hypertensive patients. This trial suggests that involving communities in genetic testing could be beneficial for reducing the risks of chronic kidney disease.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateMar 4, 2022

Study examines use of palliative care for patients with COVID-19 and acute kidney injury

A new study found that palliative care for hospitalized patients with both COVID-19 and acute kidney injury (AKI) was often called later than expected, despite the high risk of death. Palliative care supports primary doctors in managing emotional and physical symptoms while assisting in advance care planning.

SourceAmerican Society of Nephrology·JournalClinical Journal of the American Society of Nephrology·DateFeb 24, 2022

MDI Biological Laboratory scientist identifies mechanism underlying ‘inflammaging’

Researchers at MDI Biological Laboratory discovered that age-related chronic inflammation is caused by disruption of chromatin architecture. This leads to misexpression of genes lacking CpG islands, resulting in inflammation and loss of cellular function. The findings provide a unifying theory for the age-related degenerative diseases.

SourceMDI Biological Laboratory·JournalScience Advances·TypeData/statistical analysis·DateFeb 22, 2022

Obesity may increase end-stage kidney disease risk in women with type 2 diabetes

A new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism found that obesity may increase the risk of end-stage kidney disease in women with type 2 diabetes. Managing blood pressure and sugar levels is not enough to slow progression, emphasizing the need for weight management.

SourceThe Endocrine Society·JournalThe Journal of Clinical Endocrinology and Metabolism·DateFeb 22, 2022

PM2.5 reduction improves kidney function

A population-based study found that reducing ambient fine particulate matter (PM2.5) concentration led to significant improvements in laboratory test results for kidney function, including increased glomerular filtration rate and decreased blood urea nitrogen and uric acid levels.

SourceHealth Data Science·JournalHealth Data Science·TypeData/statistical analysis·DateFeb 17, 2022

Southampton-led study shows need for painkiller caution to prevent kidney damage

A recent study led by Dr Simon Fraser from the University of Southampton found that painkiller prescriptions decreased during the pandemic, but high-risk individuals continued to receive them. The research highlights the need for greater caution when prescribing non-steroidal anti-inflammatory drugs (NSAIDs) to prevent kidney damage.

SourceUniversity of Southampton·JournalBJGP Open·TypeMeta-analysis·DateFeb 17, 2022

Henry Ford Health System study finds high mortality associated with acute kidney injury

A study by Henry Ford Health System found that one in four patients who developed acute kidney injury (AKI) die within a year, emphasizing the urgent need for improved treatments. The study analyzed data from over 1.6 million U.S. Veterans hospitalized between 2008 and 2017, providing valuable insights into AKI-associated mortality.

SourceHenry Ford Health·JournalClinical Journal of the American Society of Nephrology·DateFeb 10, 2022

Gene variants increase risk of kidney failure in Black veterans with COVID-19: study

A new study published in JAMA Internal Medicine has found that gene variants increased the risk of acute kidney injury and death in African American veterans hospitalized with COVID-19. The study, which analyzed data from over 850,000 diverse veterans, identified APOL1 variants as a key contributor to this increased risk.

SourceVanderbilt University Medical Center·JournalJAMA Internal Medicine·TypeData/statistical analysis·DateFeb 10, 2022

Special testing of kidney tissue from deceased COVID-19 donor documents safe transplantation of the organ, Johns Hopkins researchers report

Researchers at Johns Hopkins Medicine have successfully transplanted a kidney from a COVID-19 donor, demonstrating that healthy kidneys from such donors can be safely transplanted. The recipient has shown no signs or symptoms of the virus and has excellent kidney function since the transplant.

SourceJohns Hopkins Medicine·JournalAmerican Journal of Transplantation·DateJan 31, 2022

Health-related quality-of-life differences in men and women with advanced kidney disease

Men and women with advanced kidney disease show differing health-related quality of life trajectories, with women experiencing lower scores initially but a more gradual decline over time. Factors such as kidney function decline, phosphate levels, and hemoglobin also influence physical and mental health scores in both men and women.

SourceAmerican Society of Nephrology·JournalClinical Journal of the American Society of Nephrology·DateJan 24, 2022